Published in
Lippincott, Williams & Wilkins, Pharmacogenetics and Genomics, 12(17), p. 1057-1064, 2007
DOI: 10.1097/fpc.0b013e3282f1b2be
Links
Tools
Cytochrome P450 2C19 loss-of-function polymorphism, but not CYP3A4 IVS10+12G/A and P2Y12 T744C polymorphisms, is associated with response variability to dual antiplatelet treatment in high-risk vascular patients:
Journal article published in 2007 by
Betti Giusti 
,
Anna Maria Gori,
Rossella Marcucci,
Claudia Saracini,
Ilaria Sestini,
Rita Paniccia,
Serafina Valente,
Davide Antoniucci,
Rosanna Abbate,
Gian Franco Gensini
,
Anna Maria Gori,
Rossella Marcucci,
Claudia Saracini,
Ilaria Sestini,
Rita Paniccia,
Serafina Valente,
Davide Antoniucci,
Rosanna Abbate,
Gian Franco Gensini
This paper is available in a repository.
Full text: Download
Published version:
archiving forbidden
Data provided by 